Archived copies of the webcasts will be available for up to one year by visiting the “Investors” section of the 4DMT website at https://ir.4dmoleculartherapeutics.com/events.

New immunology data for INO-3107 supporting proposed mechanism of action presented at several recent conferences Data showed ability of INO-3107 to induce an antigen-specific cytotoxic T cell response ...

It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal ...

Blog - The World Health Organization (WHO) has identified climate change as one of humanity's most significant health threat, with significant impacts across Africa. Rising temperatures and erratic ...

Its award-winning Vector Design Studio is a transformative innovation that ... today announced that the Company's management team will attend the Jefferies Healthcare Conference in London, November 19 ...

High dose TSHA-102 was generally well tolerated with no SAEs or DLTs in two adolescent/adult patients and one <a target=_blank href= ...

Nvidia is experiencing a perfect storm of positive catalysts, including strong demand for AI accelerators and upcoming ...

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported third quarter results and business highlights for the quarter ended September 30, 2024, including recent commercial ...

Greetings, and welcome to the Taysha Gene Therapies' third-quarter 2024 earnings call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce ...

Disclaimer: In the majority of cases, the determination of whether or not to pay a ransom is a business decision, ...

Quants often need to develop algorithmic decision rules for selecting execution strategies based on trade characteristics. While A-B testing is commonly used to evaluate potential decision rules, it ...

Abstract: Systems, eye-mountable devices, and methods that facilitate chronotherapeutic treatment of primary open-angle ...